Directors' Holdings
| Member | Shares 31/12/2020 | Options 31/12/2020 |
| Dr. Gerd Zettlmeissl, Chairman of the Supervisory Board | 0 | 0 |
| Antoinette Hiebeler-Hasner, Deputy Chair of the Supervisory Board | 0 | 0 |
| Prof. Horst Domdey (until 16/12/2020) | 39,125 | 0 |
| Dr. Yita Lee (until 16/12/2020) | 0 | 0 |
| Dr. Anthony Man (since 16/12/2020) | 0 | 0 |
| Dr. Keith Manchester1) | 0 | 0 |
| Dr. Frank Mathias | 20,197 | 46,0892) |
| Ronald Scott | 0 | 0 |
| Total Supervisory Board | 59,322 | 46,089 |
| Prof. Dr. Dolores J. Schendel, CEO3) | 846,296 | 97,500 |
| Dr. Kai Pinkernell, Member of the Executive Management Board | 0 | 73,438 |
| Axel Sven Malkomes, Member of the Executive Management Board | 0 | 75,000 |
| Total Executive Management Board | 846,296 | 245,938 |
| 1) Dr. Manchester is a partner and Head of Life Sciences QVT Financial LP New York, USA. According to the latest voting rights announcement dated 8 June 2018, the funds managed by QVT hold 1,072,879 shares in Medigene AG. 2) The stated number of options corresponds to 124,839 options prior to a capital reduction in 2013. 3) Prof. Schendel indirectly holds 846,296 Medigene shares in her capacity as Managing Director of DJSMontana Holding GmbH, which can be allocated to Prof. Schendel directly. | ||